Machine Learning Sheds Light on the Microbiome
As data availability, technology advances, and increasingly sophisticated algorithms have brought expanded applications of artificial intelligence (AI) to the fore, modern medicine has become increasingly adept at putting machine learning into practice. Among the many AI-driven precision medicine research projects is one aimed at C. difficile.
The Right Regulation for Patients: Advancing American Kidney Health
Thanks to a recent move by the federal government—informed, in part, by Partners Population Health—millions of patients with kidney disease will soon benefit from more comprehensive, patient-centered care.
With More Than 100,000 Participants, Partners Biobank Is Meeting Its Research Mission
Within the Partners HealthCare Biobank—a collection of patient blood samples combined with Partners electronic health record data and self-reported family health history—volume yields insights.
Exploring the Great Outdoors While Preventing Tick-Borne Illnesses
Summer is here, meaning more time spent outside—bringing health benefits as we engage in more activity. Those same outdoor activities, however, also carry the risk of tick exposure—and the tick-borne illnesses, including Lyme disease, they’re known to carry.
The Data-Driven Search for Safer, More Effective Drugs
How will a certain drug impact a certain patient? What behavior and lifestyle factors affect risky or inconsistent medication use? These are the questions behind pharmacoepidemiology, the multidisciplinary field that uses data points to discover how medications affect our health.
Targeting Tumors, with Help from Data Science
Can a computer find cancer before an expert oncologist? New research suggests it can.